resources

Aarti Drugs Ltd.

NSE: AARTIDRUGS

BSE: 524348

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

422.30+2.5 (+0.61%)

17 Jul, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Aarti Drugs Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	—
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar
Conference Calls	—	—	—	—	—	—	—	—	9Jun 31Aug 15Nov	14Feb 16May 3Aug 31Oct	3Feb 7May 28Jul 27Oct	1Feb 10May 5Aug 25Oct 2Nov	4Feb 25Jul 14Nov	10Feb 23May
Presentations	—	—	—	—	—	—	—	—	28Jan 17May 28Jul 27Oct	31Jan 9May 7Jun 27Jul 4Aug 20Oct	27Jan 2May 21Jul 26Sept 19Oct	24Jan 4May 26Jul 20Sept 24Oct	29Jan 6May 19Jul 24Sept 7Nov	3Feb 16May

Corporate Announcements and Regulatory Filings

Aarti Drugs Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of SEBI (DP) Regulation, 2018
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201127 Jun 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dilesh Roadlines Pvt Ltd & Others
Closure of Trading Window26 Jun 2026
Closure of Trading Window
Closure of Trading Window
Analyst / Investor Meet16 Jun 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analyst/ Institutional Meeting
Newspaper Publication16 Jun 2026
Transfer Of Equity Shares Of The Company To IEPF
Newspaper Publication
Analyst / Investor Meet5 Jun 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analyst/Institutional Investor meet
Reg.24(A)-Annual Secretarial Compliance26 May 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended March 31, 2026
Analyst / Investor Meet22 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analyst Meet
Analyst / Investor Meet18 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audit Recording of Q4 and FY26 Earning Conference Call
Newspaper Publication18 May 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Financial Results
Press Release / Media Release16 May 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Q4 and FY26 Business and Financial Performance
General15 May 2026
Re-Appointment Of Cost Auditor And Internal Auditor
Re-appointment of Cost Auditor and Internal Auditor
Outcome of Board Meeting15 May 2026
Board Meeting Outcome for Outcome Of The Board Meeting Dated May 15, 2026
Outcome of the Board Meeting - Financial Results, Re-Appointment of Internal Auditor and Cost Auditor, Reconstitute of Risk Management Committee
Analyst / Investor Meet12 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of earning conference call
Board Meeting8 May 2026
Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended March 31, 2026
Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve Audited Financial results for the ....
Newspaper Publication9 Apr 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication regarding special window for re-lodgement of transfer requests of physical shares.
Newspaper Publication7 Apr 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Second 100 days Campaign - "Saksham Niveshak".
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Apr 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP) Regulation,2018
Press Release / Media Release6 Apr 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Second 100 days Campaign - "Saksham Niveshak"
Closure of Trading Window25 Mar 2026
Closure of Trading Window
Closure of Trading Window

Frequently Asked Questions

Where can I download the annual report of Aarti Drugs Ltd.?

Annual reports of Aarti Drugs Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Aarti Drugs Ltd.?

Quarterly earnings results and presentations of Aarti Drugs Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Aarti Drugs Ltd. publish earnings call transcripts?

Earnings call transcripts of Aarti Drugs Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Aarti Drugs Ltd.?

Investor presentations and annual day presentations of Aarti Drugs Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Aarti Drugs Ltd.?

Corporate announcements and regulatory filings of Aarti Drugs Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Aarti Drugs Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Aarti Drugs Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Aarti Drugs Ltd.?

The ISIN (International Securities Identification Number) of Aarti Drugs Ltd. is INE767A01016. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Aarti Drugs Ltd. listed?

Aarti Drugs Ltd. is listed on NSE and BSE. The NSE symbol is AARTIDRUGS and the BSE code is -.

Where can I find the shareholding pattern of Aarti Drugs Ltd.?

The quarterly shareholding pattern of Aarti Drugs Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Aarti Drugs Ltd. on Sharpely?

Share price data for Aarti Drugs Ltd. is updated as of 17 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.